Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?

BACKGROUND: Neoadjuvant chemoradiotherapy has become the mainstay of treatment for locally advanced esophageal cancer. CALGB 9781 trial established cisplatin and 5-flourouracil (5-Fu) with radiotherapy as superior to surgery alone while the CROSS trial established paclitaxel, carboplatin, and radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Logarajah, Shankar, Jeyarajah, Prashan, Darwish, Muhammad, Moslim, Maitham, Jureller, Michael, Osman, Houssam, Jeyarajah, D. Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830326/
https://www.ncbi.nlm.nih.gov/pubmed/36636066
http://dx.doi.org/10.21037/jgo-22-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830326/
https://www.ncbi.nlm.nih.gov/pubmed/36636066
http://dx.doi.org/10.21037/jgo-22-70

Ejemplares similares